NIH began clinical trial testing remdesivir plus interferon beta-1a for COVID-19 treatment
On Aug. 5, 2020, a randomized, controlled clinical trial evaluating the safety and efficacy of a treatment regimen…
-
-
COVID-19 | Diagnostics | Medical Device | NIH
NIH harnessed AI for COVID-19 diagnosis, treatment, and monitoring
On Aug. 5, 2020, the National Institutes of Health (NIH) announced it had launched the Medical Imaging and…
-
NIH-Moderna investigational COVID-19 vaccine showed promise in mouse studies
On Aug. 5, 2020, the National Institute of Allergy and Infectious Diseases (NIAID) announced that the investigational vaccine…
-
NIH launched clinical trial to test antibody treatment in hospitalized COVID-19 patients
On Aug. 4, 2020, the NIH announced that patients admitted with COVID-19 at select hospitals may now volunteer…
-
Mateon and Abiogenesis to initiate clinical study to test Artemisinin as a treatment for COVID-19 in India
On Aug. 4, 2020, Mateon Therapeutics and Abiogenesis announced they had initiated a ARTI-19 randomized, controlled, multi-site India…
-
Biotechnology | COVID-19 | Diagnostics | FDA
Precipio launched Covid-19 antibody test in its CLIA laboratory
On Aug. 4, 2020, Precipio announced it had completed the internal validation of the U.S. Food and Drug…
-
Innovation Pharma and US Regional Biocontainment Laboratory updated brilacidin anti-SARS-CoV-2 in vitro testing
On Aug. 4, 2020, Innovation Pharma reported receiving an update from a U.S. Regional Biocontainment Laboratory (RBL) based…
-
FDA issued Emergency Use Authorization for Impella heart pumps to provide unloading therapy to COVID-19 patients
On Aug. 4, 2020, Abiomed announced the FDA had issued an emergency use authorization (EUA) for its left-sided…
-
Novavax announced positive phase 1 data for its COVID-19 vaccine candidate
On Aug. 4, 2020, Novavax announced Phase 1 data from its Phase 1/2 randomized, observer-blinded, placebo-controlled trial of…
-
Cocrystal Pharma announced publication of positive data demonstrating potent in vitro inhibition against Coronavirus
On Aug. 4, 2020, Cocrystal Pharma announced the publication of preclinical animal studies of coronavirus antiviral compounds in…
-
ImmunityBio study showed positive T cell and antibody immune responses to its COVID-19 vaccine candidate
On Aug. 3, 2020, ImmunityBio announced positive preclinical results for its human Ad5 vaccine candidate that contains both…
-
La Jolla Institute for Immunology received $1 million from GHR Foundation in support of COVID-19 research
On Aug. 3, 2020, the La Jolla Institute for Immunology (LJI) announced a $1 million gift from GHR…
-
Lilly initiated phase 3 trial of LY-CoV555 for prevention of COVID-19 at lLong-term care facilities in partnership with NIAID
On Aug. 3, 2020, Eli Lilly announced the initiation of BLAZE-2, a phase 3 trial studying LY-CoV555 for…
-
Pathnova Laboratories announced partnership to commercialize Todos Medicals COVID-19 and breast cancer tests in Singapore
On Aug. 3, 2020, Todos Medical announced a partnership with PATHNOVA, a Singapore-based clinical laboratory, for the Company’s…
-
Atossa Therapeutics received approval to open clinical study of AT-301 nasal spray being developed to treat COVID-19
On Aug. 3, 2020, Atossa Therapeutics announced that it had received approval from the ethics committee to open…
-
Waisman Biomanufacturing partnered with Heat Biologics to manufacture COVID-19 vaccine
On Aug. 3, 2020, Waisman Biomanufacturing at the University of WisconsinﾖMadison announced it was partnering with Heat Biologics…
-
Oxford University and ZOE partnered on COVID-19 treatment trials
On Aug. 3, 2020, the University of Oxford and the COVID Symptom Study joined forces to widen access…
-
Members of the COVID R&D alliance and quantum leap healthcare collaborative enrolled first patients in I-SPY COVID trial
On Aug. 3, 2020, members of the COVID R&D Alliance AbbVie, Amgen and Takeda Pharma announced the first…
-
NIH delivered new COVID-19 testing technologies to meet US demand
On Jul. 31, 2020, the NIH announced that it had invested $248.7 million in new technologies to address…
-
Biotechnology | COVID-19 | NIH
Quidel received NIH contract for $71 million to expand manufacturing capacity for Sofia SARS-CoV-2 antigen test for diagnosis of COVID-19
On Jul. 31, 2020, Quidel announced a preliminary contract with the NIH to support the expansion of its…
-
COVID-19 | Diagnostics | NIH
Mesa Biotech announced $154 million funding from the NIH for Accelerated scale-up and deployment
On Jul. 31, 2020, Mesa Biotech announced it had been awarded a contract up to $15.4 million from…
-
Immune system variation can predict severe COVID-19 outcomes
On Jul. 31, 2020, Yale researchers reported that differing immune system responses of patients with COVID-19 can help…
-
Sanofi and GSK announced discussions with EU to supply up to 300 million doses of COVID-19 vaccine
On Jul. 31, 2020, Sanofi and GSK announced advanced discussions, with the European Commission for the supply of…
-
Sanofi and GSK selected for Operation Warp Speed to supply US government with 100 million doses of COVID-19 vaccine
On Jul. 31, 2020, Sanofi and GSK announced a collaborative effort with the U.S. government to accelerate the…
-
RedHill Biopharma initiated global phase 2/3 study for COVID-19
On Jul. 30, 2020, RedHill Biopharma announced that it has initiated a global Phase 2/3 clinical study evaluating…
-
Biotechnology | COVID-19 | FDA
Precipio announced commercial launch of Covid-19 antibody test
On Jul. 30, 2020, Precipio announced it had entered into an agreement with ADS Biotec, based in Omaha,…
-
LabCorp announced work wth public health authorities on no-charge antibody test program to accelerate COVID-19 blood plasma donation
On Jul. 30, 2020, LabCorpﾮ launched the LabCorp At Home COVID-19 Test Collection Service, the first seamless digital…
-
Single dose of Johnson & Johnson COVID-19 vaccine candidate demonstrated robust protection in pre-clinical studies
On Jul. 30, 2020, Johnson & Johnson announced that its lead vaccine candidate protected against infection with SARS-CoV-2,…
-
INOVIO’s COVID-19 DNA vaccine INO-4800 provided protection with memory immune responses In non-human primates challenged with SARS-CoV-2 virus
On Jul. 30, 2020, INOVIO announced that its COVID-19 DNA vaccine INO-4800 targeting SARS-CoV-2 was effective in protecting…
-
BARDA procured Regeneron’s REGN-EB3 investigational Ebola treatment for national preparedness
On Jul. 29, 2020, Regeneron announced that the Biomedical Advanced Research and Development Authority (BARDA) had entered into…
